Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018-08-01 | PMID 29768118
Solomon Benjamin J, Kim Dong-Wan, Wu Yi-Long and 10 more
Genes: ALK
